Login
Toggle navigation
Videos
Categories
Trending
Julien Guerrand of TCM Capital and Martin Baumann, Co-Founder of CMCC Global, share insights as hedge fund and capital management leaders.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Julien Guerrand of TCM Capital
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
AAK AB Q1 2024 Interim Report: CEO Johan Westman’s Insights | Johan Westman, CEO , AAK AB.
00:10:00
Benefits of Financial Planning Accreditation: Insights from Fortitude Financial Planning
00:10:00
Shares the early influence and the core foundation of hard-working values|Andy Ziolkowski,Managing Partner,Cultivian Sandbox Ventures
00:10:00
How Asana Is Taking On Microsoft and Dropbox in the Workplace Management Space | Dustin Moskovitz, CEO, Asana IncASAN:NYQ
00:10:00
Navigating Family Law with Anna Bond, JD | Daniel Yerger - President of MY Wealth Planners
00:10:00
A former spacecraft engineer revolutionises the energy management industry with a breakthrough project in Anacle Systems|CEO , Anacle Systems Ltd
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
"PagerDuty CEO Jennifer Tejada discusses with 'Squawk on the Street' whether corporate priorities are starting to erode."|Jennifer Tejada is the Chairperson and CEO of PagerDuty
00:10:00
INTERCORP LATAM CEO shares a testimony about NCR Corporation, with the video garnering 1.8K views in four years.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
Kim Silberman from Cadiz Securities Discusses Eskom Rate Increase Impact and Future Outlook on CNBC Africa
00:10:00
Treatment of cancer in dogs and neurodegenerative diseases in humans.|Dr Michael Thurn,Chief Executive Officer,PharmAust Ltd
00:10:00
Provide sustainable cultivation of cannabis in greenhouses and sustainable production of activated carbon.|David Lesser, CEO,Millennium Investment Acquisition Company Inc